フロリダ州における鎌状赤血球症の臨床試験
フロリダ州内の拠点で、鎌状赤血球症に関する9件の研究が参加者を募集しています。
フロリダ州内の都市
公式研究テキスト（英語）
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- University of Florida, Jacksonville
被験者募集中第3相
12歳〜100歳 · 全性別 · 2026/09/28更新 · NCT06439082A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- Memorial Healthcare, Hollywood
被験者募集中第3相
12歳以上 · 全性別 · 2026/09/17更新 · NCT06612268A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
- Edward Jenner Research Group LLC., Plantation
- Pediatric Hematology / Oncology a division of Kidz Medical services, West Palm Beach
- St. Mary's Medical Center, West Palm Beach
被験者募集中第2/3相
12歳以上 · 全性別 · 2026/08/18更新 · NCT05431088ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- University of Florida Hemophilia Treatment Center, Gainesville
- University of Miami Comprehensive Hemophilia Treatment Center, Miami
- University of Miami Hospital and Clinics, Miami
- 他4件
被験者募集中観察研究
全年齢 · 全性別 · 2026/08/17更新 · NCT04398628Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- Golisano Children's Hospital, Fort Myers
- The Foundation for Sickle Cell Disease, Hollywood
被験者募集中第2相
12歳以上 · 全性別 · 2026/08/14更新 · NCT06699849Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
- The Foundation for Sickle Cell Disease, Hollywood
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/05更新 · NCT07224360The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
- Oncology & Hematology Associates of West Broward- Site Number : 8400029, Coral Springs
- Sylvester Comprehensive Cancer Center- Site Number : 8400020, Miami
被験者募集中第3相
10歳〜65歳 · 全性別 · 2026/07/29更新 · NCT06975865Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease
- University of Florida, Gainesville
被験者募集中第2相
6 Months – 21 Years · 全性別 · 2026/07/27更新 · NCT02675959A Long-term Follow-up Study in Patients Who Received BEAM-101
- Mayo Clinic Florida, Jacksonville
被験者募集中観察研究
14歳〜37歳 · 全性別 · 2026/01/28更新 · NCT07373639ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。